Cargando...
Cost Effectiveness of DCISionRT for Guiding Treatment of Ductal Carcinoma in Situ
The DCISionRT test estimates the risk of an ipsilateral breast event (IBE) in patients with ductal carcinoma in situ (DCIS) as well as the benefit of adjuvant radiation therapy (RT). We determined the cost-effectiveness of DCISionRT using a Markov model simulating 10-year outcomes for 60-year-old wo...
Gardado en:
| Publicado en: | JNCI Cancer Spectr |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083239/ https://ncbi.nlm.nih.gov/pubmed/32211582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa004 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|